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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of exercise-based CR for patients with stable angina compared to usual care.
B A C K G R O U N D
Description of the condition
Angina pectoris is traditionally defined as a pain, discomfort or
tightness, most commonly felt in the chest, that may radiate to
the neck, jaw and arms. It is typically gradual in onset and offset
and may be associated with breathlessness and nausea. Angina oc-
curs when the coronary arteries become narrowed and myocardial
oxygen demand exceeds oxygen supply. This leads to reversible
myocardial ischaemia or hypoxia, particularly when oxygen de-
mands are high, such as during exercise and stress. The complex
mechanisms leading to symptoms of angina are not entirely un-
derstood. Importantly, acidosis results frommyocardial ischaemia,
causing the release ofmetabolites such as adenosine andbradykinin
that stimulate the sympathetic afferent nerve pathway, eventually
transmitting the painful stimuli to the brain (Crea 1990; Foreman
1999).
It was estimated in 2013 that over 1.3 million people were living
with angina in the UK (BHF 2014); and it was thought to affect
approximately 112 million people, or 1.6% of the population
worldwide in 2010 (Vos 2012). Data suggest an annual incidence
of uncomplicated angina of 1.0% in Western men aged 45 to 65
years, with a slightly higher incidence in women in this age bracket
(Hemingway 2006; NHLBI 2012). Incidence increases with age
in both men and women aged 75 to 84 years, reaching almost 4%
(Hemingway 2006). However, age standardised angina prevalence
decreased globally from 21.9 to 20.3 per 100,000 in males and
from 17.7 to 15.9 in females between 1990 and 2010 (Moran
2014)
Angina is considered stable when there is no increase in frequency
or severity of symptoms (NICE 2011). However, the transition
from stable to unstable angina is, in reality, a continuum and with-
out clear boundaries (Montalescot 2013). We define stable angina
as chest pain and associated symptoms of cardiovascular disease
precipitated by some activity (running, walking etc.) withminimal
or non-existent symptoms at rest. We define unstable angina as
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chest pain and other symptoms of cardiovascular disease which are
of new onset (within the prior 4 to 6 weeks), worsening, becom-
ing more frequent or occurring at rest (or with minimal exertion).
Despite the term ’stable’, a diagnosis of stable angina is a chronic
medical condition associated with a low but appreciable incidence
of acute coronary events and increasedmortality.Management op-
tions include lifestyle advice, drug therapy and revascularisation,
which aim to minimise symptoms, and improve quality of life and
long-term morbidity and mortality.
Although it can be precipitated by a number of conditions, stable
angina is considered to be a symptom of coronary heart disease
(CHD), which is the single most common cause of global mortal-
ity, and accounts for approximately one-third of all deaths world-
wide, placing a major economic and resource burden on health
systems (WHO 2014).
Description of the intervention
As previously described (Anderson 2016a), many definitions of
cardiac rehabilitation (CR) have been proposed (for example,
Balady 2011; BACPR 2012; WHO 1993). The following defini-
tion encompasses the key concepts of CR: “The coordinated sum
of activities required to influence favourably the underlying cause
of cardiovascular disease, as well as to provide the best possible
physical, mental and social conditions, so that the patients may,
by their own efforts, preserve or resume optimal functioning in
their community and through improved health behaviour, slow or
reverse progression of disease” (BACPR 2012). Cardiac rehabili-
tation is a complex intervention that may involve a variety of ther-
apies, including exercise, risk factor education, behaviour change,
psychological support, and strategies that are aimed at targeting
traditional risk factors for cardiovascular disease. Cardiac rehabili-
tation is an essential part of contemporary heart disease care and is
considered a priority in countries with a high prevalence of CHD.
Based on evidence from previous meta-analyses and systematic re-
views, exercise-based CR following a cardiac event is a Class I rec-
ommendation from the American College of Cardiology/Ameri-
can Heart Association (Balady 2011; Kulik 2015), and the Euro-
pean Society of Cardiology (Roffi 2015; Smith 2011; Steg 2012).
Service provision, though predominantly hospital-based, varies
markedly; and referral, enrolment and completion are sub-opti-
mal, especially among women and older people (Beswick 2004;
Clark 2012).Home-basedCRprogrammes have been increasingly
introduced to widen access and participation (Taylor 2010), and
interventions aimed at improving patient uptake and adherence
to CR programmes have been adopted (Karmali 2014).
Exercise-based CR in selected patient groups is remarkably safe.
An observational study of more than 25,000 patients who under-
went CR following cardiac surgery, recent percutaneous coronary
intervention (PCI) or with other coronary and noncoronary con-
ditions, reported one cardiac event for 50,000 hours of exercise
training, equivalent to 1.3 cardiac arrests permillion patient-hours
(Pavy 2006). An earlier study reported one case of ventricular fib-
rillation per 111,996 patient-hours of exercise and one myocar-
dial infarction (MI) per 294,118 patient-hours (Van Camp 1986).
However, patients with unstable angina, uncontrolled ventricular
arrhythmia, and severe heart failure (New York Heart Association
level 4) have been considered at high risk, and careful assessment
by an experienced clinician is recommended before they engage in
the exercise component of CR (BACPR 2012). Historically, CR
has often not been routinely offered to people with stable angina.
Indeed, 20% of all CR programmes included in the 2009 UK na-
tional audit of CR actively excluded stable angina (Lewin 2010).
In the latest UK audit, angina referrals accounted for less than 4%
of the 82,000 patients receiving CR, although 27% of all patients
were reported as having co-morbid angina at the point of entry to
their CR programme (Doherty 2015).
How the intervention might work
As previously described by the authors, the precise mechanisms by
which exercise training improves mortality in CHD patients have
not been fully elucidated (Anderson 2016a; Taylor 2006). Exer-
cise training has been shown to have direct benefits on the heart
and coronary vasculature, including myocardial oxygen demand,
endothelial function, autonomic tone, coagulation and clotting
factors, inflammatory markers, and the development of coronary
collateral vessels (Clausen 1976; Hambrecht 2000; Lavie 2015).
However, it has been suggested that approximately half of the 28%
reduction in cardiac mortality in patients with CHD may also be
mediated via the indirect effects of exercise through improvements
in the risk factors for atherosclerotic disease (i.e. total cholesterol,
smoking and blood pressure) (Taylor 2006). Further reductions in
mortality may be attributed to reductions in psychological stress,
including depression, anxiety and hostility (Lavie 2011).
Why it is important to do this review
The AmericanCollege of Cardiology/American Heart Association
give a Class I recommendation that medically supervised CR pro-
grams and physician-directed, home-based programmes are of-
fered to at-risk patients with stable CHD including those with
stable angina, at first diagnosis (Fihn 2012). Similarly, the Euro-
pean Society of Cardiology recommends that patients with sta-
ble CHD, including stable angina, should undergo “moderate-
to-vigorous intensity aerobic exercise training ≥ 3 times a week
and for 30 min per session” (Montalescot 2013). Meanwhile, the
British Association for Cardiovascular Prevention and Rehabili-
tation (BACPR) recommend CR for people following a cardiac
event, with heart failure, and to those with other established forms
of cardiovascular disease, including stable angina (BACPR 2012).
Yet despite these guidelines, the current National Institute for
Health and Care Excellence (NICE) guideline for the manage-
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ment of stable angina (CG126) states that there is “no evidence to
suggest that CR is clinically or cost effective for managing stable
angina“ (NICE 2011). NICE reports that while there has been
limited research on short-term outcomes such as a change in diet
or exercise levels, the effect on morbidity and mortality has not
been studied, and they highlight research into CR for this patient
population as one of their key research recommendations (NICE
2011).
Previous Cochrane Reviews have looked at the effect of exercise-
based CR in patients with CHD (Anderson 2016a), heart fail-
ure (Taylor 2014), and after heart valve surgery (Sibilitz 2016). A
meta-analysis of 63 trials, which randomised 14,486 patients with
CHD (including those with angina) to exercise-based CR or a no-
exercise control, showed that exercise-based CR led to a reduction
in cardiovascular mortality (relative risk (RR) 0.74, 95% confi-
dence interval (CI) 0.64 to 0.86), hospital admissions (RR 0.82,
95% CI 0.70 to 0.96) and an increase in health-related quality
of life (HRQL) (Anderson 2016a). However, many trials in this
review were in a mixed population of CHD patients (Anderson
2016a). Given the NICE key research recommendations, we be-
lieve there is a good case for separating out the evidence for CR in
stable angina. Our scoping searches have confirmed that no sys-
tematic review has been conducted which has specifically assessed
the impact of CR in a population in patients with stable angina.
O B J E C T I V E S
To assess the effects of exercise-based CR for patients with stable
angina compared to usual care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include randomised controlled trials (RCTs) with a parallel
group, cluster-randomised, or cross-over design, which compare
the independent effects of exercise-based CR versus a usual care or
no-exercise comparator. We will only include RCTs with a follow-
up period of at least six months, in order to reflect current practice
of guideline and policy writing which are driven by long-term
health benefits (NICE 2010; SIGN 2007).
Types of participants
We will include adult men and women (≥ 18 years) who have
stable angina and have been diagnosed with coronary heart dis-
ease. We will include people who have presented with stable or
exertional angina (effort-induced chest discomfort), who are being
treated with medical antianginal therapy and who may have had a
previous myocardial infarction (MI), coronary artery bypass graft
(CABG) or percutaneous coronary intervention (PCI). However,
we will exclude people in the immediate period following such an
event, i.e. within 3 months of MI, PCI or CABG. We will also
exclude people with unstable angina (pain at rest) and those with
refractory angina for whom revascularisation is planned.
We will include studies with a mixed population of patients with
CHD, where the data for those with stable angina and without
any confounding co-morbidities are reported separately. We will
also include studies where the majority of the participant sample
(50% or more) are reported to have stable angina, regardless of
whether data for this sub-population are reported separately.
Types of interventions
Exercise-based CR is defined as a supervised or unsupervised in-
patient, outpatient, centre- or home-based intervention which in-
cludes some form of exercise training that is applied to a cardiac
patient population. The intervention could be exercise training
alone or exercise training in addition to psychosocial or educa-
tional interventions, or both (i.e. ’comprehensive CR’).
The comparator group could include usual or standard medical
care, such as drug therapy, but without any form of structured
exercise training or advice. We will include studies designed to as-
sess the independent effect of exercise (e.g. exercise plus usual care
versus usual care alone; exercise, usual care and education versus
usual care and education alone). However, we will also include
studies which compare exercise to an active intervention such as
education, behavioural or psychological interventions or surgery.
Types of outcome measures
Primary outcomes
1. All-cause mortality.
2. Morbidity - myocardial infarction (MI), revascularisation
(CABG or PCI) or all-cause hospital admissions, or
combinations thereof.
3. Health-related quality of life (HRQoL) assessed using
validated instruments (e.g. 36-Item Short Form Health Survey
(SF-36), EQ-50).
4. Exercise capacity assessed by validated outcome measure
(e.g. VO peak, 6-minute walk test).
5. Cardiovascular-related hospital admissions.
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Secondary outcomes
1. Severity of angina, assessed using validated instruments
(e.g. Canadian Cardiovascular Society grading of angina pectoris;
New York Heart Association Functional Classification of
Angina).
2. Reported adverse events (clinical events relating to CR e.g.
skeletomuscular injuries or arrhythmias or withdrawal from the
intervention, or combinations thereof ).
3. Return to work.
4. Costs.
Reporting one of more of the outcomes listed here in the trial is
not an inclusion criterion for the review.
Search methods for identification of studies
Electronic searches
Wewill identify trials through systematic searches of the following
bibliographic databases.
• Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library.
• MEDLINE (Ovid) Epub Ahead of Print, In-Process &
Other Non-Indexed Citations, MEDLINE daily and
MEDLINE.
• Embase Classic and Embase (Ovid).
• CINAHL Plus (EBSCO).
• Database of Abstracts of Reviews of Effects (DARE).
• Health Technology Assessment (HTA).
• Web of Science Core Collection (Thomson Reuters).
We will design the search strategies with reference to those of
a previous and related Cochrane Review of exercise-based CR
(Anderson 2016b). We will search the databases using a strategy
combining selected MeSH terms and free-text terms relating to
exercise-based rehabilitation and stable angina, with filters applied
to limit to RCTs. We will use the Cochrane sensitivity-maximis-
ing RCT filter for MEDLINE, and apply terms recommended in
the Cochrane Handbook for Systematic Reviews of Interventions for
Embase (Lefebvre 2011). We will apply adaptations of this filter
to CINAHL and Web of Science. We will translate the MED-
LINE (Ovid) search strategy (Appendix 1) for use with the other
databases using the appropriate controlled vocabulary as applica-
ble.Wewill search all databases from their inception to the present,
we will impose no restriction on language of publication and will
give consideration to variations in terms used and spellings of
terms in different countries so that the search strategy will not miss
studies because of such variations.
Searching other resources
We will handsearch reference lists, and conduct forward citation
searching, of all primary studies and review articles for additional
references not identified by the electronic searches. We will con-
duct a search of World Health Organization International Clini-
cal Trials Registry Platform (WHO ICTRP; www.who.int/ictrp/
en) and ClinicalTrials.gov (ClinicalTrials.gov)) for ongoing clini-
cal trials. We will also contact experts in the field for unpublished
and ongoing trials and will contact trial authors where necessary
for any additional information. We will also examine any relevant
retraction statements and errata for included studies.
Data collection and analysis
Selection of studies
Two review authors will independently screen titles and abstracts
for inclusion of all the potential studies we identify as a result of the
search and code them as ’retrieve’ (eligible or potentially eligible/
unclear) or ’do not retrieve’. If there are any disagreements, a third
author will be asked to arbitrate.We will retrieve the full-text study
reports/publication and two review authors will independently
screen the full text and identify studies for inclusion, and identify
and record reasons for exclusion of the ineligible studies. We will
resolve any disagreement through discussion or, if required, we
will consult a third person.We will identify and exclude duplicates
and collate multiple reports of the same study so that each study
rather than each report is the unit of interest in the review. We
will record the selection process in sufficient detail to complete a
PRISMA flow diagram and ’Characteristics of excluded studies’
table.
Data extraction and management
We will use a data collection form for study characteristics and
outcome data which has been piloted on at least one study in the
review. One review author will extract study characteristics from
included studies. We will extract the following study characteris-
tics.
1. Methods: study design, total duration of study, number of
study centres and location, study setting, withdrawals, and date
of study.
2. Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, inclusion criteria, and exclusion
criteria.
3. Interventions: intervention, comparison, and co-
interventions.
4. Outcomes: primary and secondary outcomes specified and
collected, and time points reported.
5. Notes: funding for trial, and notable conflicts of interest of
trial authors.
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Two review authors will independently extract outcome data from
included studies. We will resolve disagreements by consensus or
by involving a third person. One review author will transfer data
into the Review Manager 5 file (Review Manager 2014). We will
double-check that data is entered correctly by comparing the data
presented in the systematic reviewwith the study reports. A second
review author will check study characteristics for accuracy against
the trial report.
Assessment of risk of bias in included studies
Two review authors will independently assess risk of bias for each
study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We will resolve
any disagreements by discussion or by involving another author.
We will assess the risk of bias according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of outcome assessment.
4. Incomplete outcome data.
5. Selective outcome reporting.
6. Other (specifically sources of funding and conflicts of
interest).
We will also assess two further quality criteria: whether the study
groups were balanced at baseline; and if the study groups received
comparable care (apart from the exercise component of the in-
tervention). These criteria, agreed upon in advance by the review
authors, have not been validated but have been used to assess qual-
ity in previous CR reviews (Anderson 2016a; Anderson 2016b;
Brown 2011; Sibilitz 2016; Taylor 2014; Taylor 2015). We will
assess these two further quality criteria as follows.
Groups balanced at baseline
• Low risk of bias: The characteristics of the participants in
the intervention and control groups at baseline are reported to be
comparable or can be judged to be comparable (e.g. baseline data
reported in Table 1) in terms of likely main prognostic factors.
• Unclear risk of bias: Whether the characteristics of the
participants in the intervention and control groups are balanced
at baseline is not reported, and reported information is
inadequate to assess this (e.g. no Table 1).
• High risk of bias: There is evidence of substantive imbalance
in the baseline characteristics of the intervention and control
groups with regard to likely major prognostic factors.
Groups received comparable treatment (except exercise)
• Low risk of bias: All co-interventions were delivered equally
across intervention and control groups.
• Unclear risk of bias: Information to assess whether co-
interventions were delivered equally across groups was
insufficient.
• High risk of bias: The co-interventions were not delivered
equally across intervention and control groups.
We will grade each potential source of bias as high, low, or un-
clear and provide a quote from the study report together with a
justification for our judgement in the ’Risk of bias’ table. We will
summarise the ’Risk of bias’ judgements across different studies
for each of the domains listed. Where information on risk of bias
relates to unpublished data or correspondence with an author, we
will note this in the ’Risk of bias’ table.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
Assessment of bias in conducting the systematic
review
We will conduct the review according to this published protocol
and will report any deviations from it in the ’Differences between
protocol and review’ section of the systematic review.
Measures of treatment effect
We will analyse dichotomous data as risk ratios with 95% confi-
dence intervals and continuous data as mean difference with 95%
confidence intervals. For any outcomes which are measured by
studies in a variety of ways (for example, some studiesmaymeasure
exercise capacity using VO2peak , and others using the 6-minute
walk test), the standardised mean difference with 95% confidence
intervals will be used as the summary statistic. We will enter data
presented as a scale with a consistent direction of effect.
We will narratively describe skewed data reported as medians and
interquartile ranges.
Unit of analysis issues
In accordance with Section 16.4 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011), we will aim to
include data from both periods of any cross-over trials identified,
assuming (i) there has been a wash-out period considered long
enough to reduce carry-over, (ii) no irreversible events such as
mortality have occurred, and (iii) appropriate statistical approaches
have been used.
Dealing with missing data
We will contact investigators or study sponsors to verify key study
characteristics and obtain missing numerical outcome data where
possible (for example when a study is identified as abstract only).
Where this is not possible, and the missing data are thought to
introduce serious bias, we will explore the impact of including
such studies on the overall assessment of results by a sensitivity
analysis.
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Assessment of heterogeneity
We will explore heterogeneity amongst included studies qualita-
tively (by comparing the characteristics of included studies) and
quantitatively (using the Chi² test of heterogeneity and I² statis-
tic). We will use a threshold of I² greater than 50% (considered
to represent substantial heterogeneity (Deeks 2011)) for both di-
chotomous and continuous outcomes to determine the statistical
model to be used for meta-analysis.
Assessment of reporting biases
If we are able to pool more than 10 trials, we will create and
examine a funnel plot and the Egger test to explore possible small-
study biases for the primary outcomes (Egger 1997).
Data synthesis
Wewill undertakemeta-analyses only where this ismeaningful, i.e.
if the treatments, participants and the underlying clinical question
are similar enough for pooling to make sense.
Dichotomous outcomes for each comparison will be expressed as
risk ratios with 95% confidence intervals. Continuous data will be
expressed as mean difference with 95% confidence intervals, or,
where an outcome ismeasured and reported inmore than one way,
as standardised mean difference with 95% confidence intervals.
Wewill enter data presented as a scale with a consistent direction of
effect. If there is a statistically significant absolute risk difference,
we will aim to calculate the associated number needed to treat for
an additional beneficial or harmful outcome.
Where appropriate, we will pool data from each study using a
fixed-effect model, except where substantial heterogeneity exists.
If possible, we will pool the results for HRQL using a standard-
ised mean difference. If there is evidence of substantial statistical
heterogeneity (P value less than 0.10, I² greater than 50%) associ-
ated with an effect estimate, we will apply a random-effects model,
which provides a more conservative statistical comparison of the
difference between intervention and control because a confidence
interval around the effect estimate is wider than a confidence in-
terval around a fixed-effect estimate. If a statistically significant
difference is still present using the random-effects model, we will
also report the fixed-effect pooled estimate and 95% confidence
interval because of the tendency of smaller trials, which are more
susceptible to publication bias, to be over-weighted with a ran-
dom-effects analysis (Heran 2008a; Heran 2008b).
We will process data in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). We will
complete data synthesis and analyses using Review Manager 5
software (Review Manager 2014). Meta-regression analysis will be
conducted using the ”metareg“ command in Stata version 14.2
(Stata 2015).
’Summary of findings’ table
We will employ the GRADE approach to interpret result findings
(Schünemann 2011) and use GRADEpro GDT 2015 to import
data from Review Manager 5 to create a ’Summary of findings
table’. We will aim to create a ’Summary of findings’ table using
the following outcomes: all-cause mortality, myocardial infarction
(MI), all-cause hospital admissions, HRQL, adverse events, return
to work, and exercise capacity. We will use the five GRADE con-
siderations (study limitations, consistency of effect, imprecision,
indirectness, and publication bias) to assess the quality of a body
of evidence as it relates to the studies that contribute data to the
meta-analyses for the prespecified outcomes. We will use methods
and recommendations described in Section 8.5 and Chapter 12
of the Cochrane Handbook for Systematic Reviews of Interventions
using GRADEpro software (Higgins 2011). We will justify all de-
cisions to downgrade the quality of studies using footnotes, and
will make comments to aid readers’ understanding of the review
where necessary.
Subgroup analysis and investigation of heterogeneity
We anticipate length of follow-up to be a driver of intervention
effect, with the size of effect for some outcomes being related to
the length of the follow-up. We will therefore aim to stratify meta-
analysis of each outcome according to the length of trial duration:
i.e. ’short-term’ follow-up (6 to 12 months); ’medium-term’ fol-
low-up (13 to 36 months); and ’long-term’ follow-up (more than
36 months). We will also aim to undertake univariate meta-re-
gression to explore heterogeneity and examine potential treatment
effect modifiers. We will aim to test the following hypotheses re-
garding differences in the effect of exercise-based CR on all-cause
mortality, morbidity, health-related quality of life and exercise ca-
pacity across particular subgroups (Anderson 2016a).
1. Type of CR (exercise-only CR versus comprehensive CR)
(categorical variable).
2. ’Dose’ of exercise intervention [dose = number of weeks of
exercise training × average number of sessions/week × average
duration of session in minutes] (dose ≥ 1000 units versus dose <
1000 units) (continuous variable).
3. Follow-up period (continuous variable).
4. Year of publication (≤1995 and >1995) (continuous
variable) - timing reflects the introduction of modern-day drug
therapy for the management of CHD.
5. Sample size (continuous variable).
6. Setting (home- or centre-based CR) (categorical variable).
7. Study location (continent) (categorical variable).
8. Mean age of participants (continuous variable).
9. Percentage of male participants (continuous variable).
10. Percentage of patients with previous MI, CABG surgery or
PCI (continuous variables).
Given the anticipated small ratio of trials to co-variates, meta-
regression will be limited to univariate analysis (Higgins 2011).
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However, given the anticipated small number of included studies,
we recognise that it would be unlikely that meta-regression or a
stratified meta-analysis will be possible.
We will aim to extract results of subgroup analyses, including par-
ticipant-level subgroup analyses, if reported by individual included
studies; for example, if a trial reports whether there was a differ-
ence in the effectiveness of CR between males and females.
Sensitivity analysis
We will compare meta-analysis results of including all studies ver-
sus only including those studies judged to have overall low risk of
bias (low risk in ≥ four items).
Reaching conclusions
We will base our conclusions only on findings from the quantita-
tive or narrative synthesis of included studies for this review. We
will avoid making recommendations for practice and our impli-
cations for research will suggest priorities for future research and
outline what the remaining uncertainties are in the area.
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A P P E N D I C E S
Appendix 1. Preliminary MEDLINE (Ovid) search strategy
MEDLINE
1 angina pectoris/ or angina, stable/
2 angina.tw.
3 stenocardia*.tw.
4 angor pectoris.tw.
5 1 or 2 or 3 or 4
6 exp Exercise Therapy/
7 Sports/
8 Physical Exertion/
9 rehabilitat*.tw.
10 (physical* adj5 (fit* or train* or therap* or activit*)).tw.
11 exp Exercise/
12 (train* adj5 (strength* or aerobic* or exercise*)).tw.
13 ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
14 exp Rehabilitation/
15 kinesiotherap*.tw.
16 ”Physical Education and Training“/
17 Patient Education as Topic/
18 (patient* adj5 educat*).tw.
19 ((lifestyle or life-style) adj5 (interven* or program* or treatment*)).tw.
20 Self Care/
21 (self adj5 (manag* or care or motivate*)).tw.
22 exp Psychotherapy/
23 psychotherap*.tw.
24 (psycholog* adj5 intervent*).tw.
25 Counseling/
26 (counselling or counseling).tw.
27 ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.
28 (psycho-educat* or psychoeducat*).tw.
29 (motivat* adj5 (intervention or interv*)).tw.
30 Health Education/
31 (health adj5 educat*).tw.
32 (psychosocial or psycho-social).tw.
33 (cognitive adj2 behav*).tw.
34 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
or 29 or 30 or 31 or 32 or 33
35 randomized controlled trial.pt.
36 controlled clinical trial.pt.
37 randomized.ab.
38 placebo.ab.
39 drug therapy.fs.
40 randomly.ab.
41 trial.ab.
42 groups.ab.
43 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42
44 exp animals/ not humans.sh.
45 43 not 44
46 5 and 34 and 45
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